31. Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial. Issue 3 (March 2019) Authors: Loi, Sherene; Giobbie-Hurder, Anita; Gombos, Andrea; Bachelot, Thomas; Hui, Rina; Curigliano, Giuseppe; Campone, Mario; Biganzoli, Laura; Bonnefoi, Hervé; Jerusalem, Guy; Bartsch, Rupert; Rabaglio-Poretti, Manuela; Kammler, Roswitha; Maibach, Rudolf; Smyth, Mark J; Di Leo, Angelo; Colleoni, Marco... Journal: Lancet oncology Issue: Volume 20:Issue 3(2019) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: results of the CECOG LaVie trial. Issue 1 (December 2016) Authors: Thallinger, Christiane; Lang, Istvan; Kuhar, Cvetka; Bartsch, Rupert; Singer, Christian; Petruzelka, Lubos; Melichar, Bohuslav; Knittelfelder, Regina; Brodowicz, Thomas; Zielinski, Christoph Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Plasma HMGB‐1 after the initial dose of epirubicin/docetaxel in cancer. (25th January 2013) Authors: Arnold, Tobias; Michlmayr, Anna; Baumann, Suzann; Burghuber, Christopher; Pluschnig, Ursula; Bartsch, Rupert; Steger, Guenther; Gnant, Michael; Bergmann, Michael; Bachleitner‐Hofmann, Thomas; Oehler, Rudolf Journal: European journal of clinical investigation Issue: Volume 43:Number 3(2013:Mar.) Page Start: 286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy. (25th July 2016) Authors: Exner, Ruth; Sachet, Monika; Arnold, Tobias; Zinn‐Zinnenburg, Mercedes; Michlmayr, Anna; Dubsky, Peter; Bartsch, Rupert; Steger, Guenther; Gnant, Michael; Bergmann, Michael; Bachleitner‐Hofmann, Thomas; Oehler, Rudolf Journal: Cancer medicine Issue: Volume 5:Number 9(2016:Sep.) Page Start: 2350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Results from the FeDeriCa trial: are we reducing the burden of breast cancer treatment?. Issue 1 (January 2021) Authors: Bartsch, Rupert; Minichsdorfer, Christoph; Kolberg-Liedtke, Cornelia Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. The cancer survival index—A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies. (22nd March 2022) Authors: Gaiger, Alexander; Lubowitzki, Simone; Krammer, Katharina; Zeilinger, Elisabeth L.; Acel, Andras; Cenic, Olivera; Schrott, Andrea; Unseld, Matthias; Rassoulian, Anahita Paula; Skrabs, Cathrin; Valent, Peter; Gisslinger, Heinz; Marosi, Christine; Preusser, Matthias; Prager, Gerald; Kornek, Gabriel... Journal: Cancer medicine Issue: Volume 11:Number 18(2022) Page Start: 3387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. The impact of COVID‐19 on cancer care of outpatients with low socioeconomic status. Issue 1 (17th February 2022) Authors: Zeilinger, Elisabeth L.; Lubowitzki, Simone; Unseld, Matthias; Schneckenreiter, Carmen; Heindl, Daniel; Staber, Philipp B.; Raderer, Markus; Valent, Peter; Zöchbauer‐Müller, Sabine; Bartsch, Rupert; Prager, Gerald; Jaeger, Ulrich; Gaiger, Alexander Journal: International journal of cancer Issue: Volume 151:Issue 1(2022) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. The iTOP trial: Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cancer - A prospective, controlled, single-center study. (August 2022) Authors: Bolliger, Michael; Lanmüller, Pia; Schuetz, Michael; Heilig, Bernhard; Windischbauer, Amadeus; Jakesz, Raimund; Zehetgruber, Tanja; Gnant, Michael; Gleiss, Andreas; Dörfler, Daniela; Singer, Christian; Bartsch, Rupert; Haslik, Werner; Montagna, Giacomo; Fitzal, Florian Journal: International journal of surgery Issue: Volume 104(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study. Issue 3 (6th May 2019) Authors: Obermeier, Hanna L.; Riedl, Julia; Ay, Cihan; Koder, Silvia; Quehenberger, Peter; Bartsch, Rupert; Kaider, Alexandra; Zielinski, Christoph C.; Pabinger, Ingrid Journal: Research and practice in thrombosis and haemostasis Issue: Volume 3:Issue 3(2019) Page Start: 503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field. Issue 5 (13th October 2020) Authors: Marhold, Maximilian; Topakian, Thais; Agis, Hermine; Bartsch, Rupert; Berghoff, Anna S; Brodowicz, Thomas; Fuereder, Thorsten; Ilhan-Mutlu, Aysegül; Kiesewetter, Barbara; Krainer, Michael; Locker, Gottfried J; Marosi, Christine; Prager, Gerald; Schmidinger, Manuela; Thallinger, Christiane; Zöchba... Journal: ESMO open Issue: Volume 5:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗